Ghaleb Elyamany

727 total citations
49 papers, 393 citations indexed

About

Ghaleb Elyamany is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Ghaleb Elyamany has authored 49 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 11 papers in Pathology and Forensic Medicine and 10 papers in Genetics. Recurrent topics in Ghaleb Elyamany's work include Acute Myeloid Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (10 papers) and Acute Lymphoblastic Leukemia research (7 papers). Ghaleb Elyamany is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (10 papers) and Acute Lymphoblastic Leukemia research (7 papers). Ghaleb Elyamany collaborates with scholars based in Saudi Arabia, Egypt and Canada. Ghaleb Elyamany's co-authors include Adnan Mansoor, Douglas A. Stewart, Noraidah Masir, Sunita Ghosh, Fariborz Rashid-Kolvear, Maha El-Zimaity, Mohammed Awad, Etienne Mahé, Bruce F. Burns and Raja Zahratul Azma Raja Sabudin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Clinical Pathology.

In The Last Decade

Ghaleb Elyamany

41 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghaleb Elyamany Saudi Arabia 11 124 96 90 69 68 49 393
Joanna Rupa‐Matysek Poland 11 171 1.4× 131 1.4× 62 0.7× 56 0.8× 78 1.1× 43 392
István Szegedi Hungary 11 92 0.7× 48 0.5× 60 0.7× 19 0.3× 26 0.4× 52 410
Anna D. Petropoulou France 13 355 2.9× 84 0.9× 121 1.3× 23 0.3× 82 1.2× 25 542
Jon Helgestad Denmark 11 207 1.7× 109 1.1× 33 0.4× 43 0.6× 38 0.6× 30 448
Apurva Patel India 13 111 0.9× 19 0.2× 120 1.3× 79 1.1× 49 0.7× 80 435
José Mariz Portugal 11 110 0.9× 37 0.4× 67 0.7× 29 0.4× 40 0.6× 41 362
Georgia McCaughan Australia 10 86 0.7× 43 0.4× 82 0.9× 27 0.4× 17 0.3× 29 265
Tariq Kewan United States 11 108 0.9× 40 0.4× 68 0.8× 31 0.4× 43 0.6× 70 407
Vanesa Caruso United States 4 208 1.7× 228 2.4× 50 0.6× 65 0.9× 68 1.0× 5 432
Nathalie Garnier France 12 116 0.9× 16 0.2× 82 0.9× 40 0.6× 117 1.7× 42 373

Countries citing papers authored by Ghaleb Elyamany

Since Specialization
Citations

This map shows the geographic impact of Ghaleb Elyamany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghaleb Elyamany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghaleb Elyamany more than expected).

Fields of papers citing papers by Ghaleb Elyamany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghaleb Elyamany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghaleb Elyamany. The network helps show where Ghaleb Elyamany may publish in the future.

Co-authorship network of co-authors of Ghaleb Elyamany

This figure shows the co-authorship network connecting the top 25 collaborators of Ghaleb Elyamany. A scholar is included among the top collaborators of Ghaleb Elyamany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghaleb Elyamany. Ghaleb Elyamany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elyamany, Ghaleb, et al.. (2025). HOX-PBXUp-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AMLviaWNT Signaling. Anticancer Research. 45(5). 2079–2089.
2.
Mansoor, Adnan, Emina Torlakovic, Tariq Roshan, et al.. (2023). Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways. Modern Pathology. 36(8). 100198–100198. 3 indexed citations
3.
4.
Chentoufi, Aziz Alami, et al.. (2022). HLA Diversity in Saudi Population: High Frequency of Homozygous HLA Alleles and Haplotypes. Frontiers in Genetics. 13. 898235–898235. 3 indexed citations
5.
Elyamany, Ghaleb, et al.. (2021). Cytological Diagnosis of Plasmablastic Lymphoma Involving the Parotid Gland: A Case Report with Review of the Literature. Case Reports in Oncology. 14(1). 244–248. 1 indexed citations
6.
Elyamany, Ghaleb, et al.. (2021). Unusual Presentation of COVID-19 in a Child Complicated by Massive Acute Pulmonary Embolism and Lung Infarction. Hematology Reports. 13(1). 8874–8874. 1 indexed citations
7.
Elyamany, Ghaleb, et al.. (2021). Clinicopathologic features and therapy outcome in childhood Hodgkin’s lymphoma: a report from tertiary care center in Saudi Arabia. Journal of the Egyptian National Cancer Institute. 33(1). 21–21. 2 indexed citations
8.
9.
Asiri, Mohammed, et al.. (2019). Routine Preoperative Coagulation Tests in Children Undergoing Elective Surgery or Invasive Procedures: Are They Still Necessary?. SHILAP Revista de lepidopterología. 12. 1179545X18821158–1179545X18821158. 11 indexed citations
10.
Elyamany, Ghaleb, et al.. (2019). Rare cytogenetic abnormalities and their clinical relevance in pediatric acute leukemia of Saudi Arabian population. Molecular Cytogenetics. 12(1). 42–42. 2 indexed citations
11.
Elyamany, Ghaleb, et al.. (2017). Erdheim-Chester Disease: Case Report with Aggressive Multisystem Manifestations and Review of the Literature. Case Reports in Oncology. 10(2). 501–507. 4 indexed citations
12.
Sabudin, Raja Zahratul Azma Raja, et al.. (2017). Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia. Journal of Clinical Pathology. 71(3). 215–220. 11 indexed citations
13.
Elzein, Fatehi, et al.. (2016). Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder. SHILAP Revista de lepidopterología.
14.
Elyamany, Ghaleb, et al.. (2016). Simultaneous existence of acute myeloid leukemia and chronic lymphocytic leukemia: a case report. BMC Cancer. 16(1). 739–739. 6 indexed citations
15.
Mughal, Muhammad Kashif, Ghaleb Elyamany, Gary Sinclair, et al.. (2016). Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients. Diagnostic Pathology. 11(1). 89–89. 6 indexed citations
16.
Elyamany, Ghaleb, et al.. (2016). Prevalence of Syphilis among Blood and Stem Cell Donors in Saudi Arabia: An Institutional Experience. SHILAP Revista de lepidopterología. 8(8). 2747–2751. 5 indexed citations
17.
Patel, Jay, Abid Qureshi, Ghaleb Elyamany, et al.. (2015). De Novo Acute Myeloid Leukemia in Adults. Applied immunohistochemistry & molecular morphology. 23(10). 733–739. 1 indexed citations
18.
Elyamany, Ghaleb, et al.. (2014). A Novel Approach for the Enumeration of Peripheral Blood Stem Cells Suitable for Transplantation. SHILAP Revista de lepidopterología. 2014. 1–7. 3 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Rupa‐Matysek Breakdown of academic impact, for papers by István Szegedi Breakdown of academic impact, for papers by Anna D. Petropoulou Breakdown of academic impact, for papers by Jon Helgestad Breakdown of academic impact, for papers by Apurva Patel Breakdown of academic impact, for papers by José Mariz Breakdown of academic impact, for papers by Georgia McCaughan Breakdown of academic impact, for papers by Tariq Kewan Breakdown of academic impact, for papers by Vanesa Caruso Breakdown of academic impact, for papers by Nathalie Garnier
Rankless by CCL
2026